Inflammatory Links Between High Fat Diets and Diseases.

Duan Y, Zeng L, Zheng C, Song B, Li F, Kong X, Xu K. · 2018

Read Inflammatory Links Between High Fat Diets and Diseases. by Duan Y, Zeng L, Zheng C, Song B, Li F, Kong X, Xu K. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6243058.txt.

Introduction

Duan and co-authors review links between high-fat diets and disease. Eating too much fat is a changeable risk factor. It links to diabetes and some cancers. How it harms health is still poorly understood. The review appeared in Frontiers in Immunology.

The authors focus on inflammation as the bridge. A high-fat diet can trigger lasting inflammation. That inflammation then feeds disease growth. Cancer development is covered as well. The review sets out the main mechanisms involved. Gut changes and immune shifts both feature. The authors argue that grasping these paths matters. The world intake of high-fat food keeps rising. Better knowledge could guide new treatment strategies.

Catalog record

CREATORDuan Y, Zeng L, Zheng C, Song B, Li F, Kong X, Xu K.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6243058

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Inflammatory Links Between High Fat Diets and Diseases By Yehui Duan, Liming Zeng, Changbing Zheng, Bo Song, Fengna Li, Xiangfeng Kong, Kang Xu Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2018.02649 ABSTRACT In recent years, chronic overnutrition, such as consumption of a high-fat diet (HFD), has been increasingly viewed as a significant modifiable risk factor for diseases such as diabetes and certain types of cancer. However, the mechanisms by which HFDs exert adverse effects on human health remains poorly understood. Here, this paper will review the recent scientific literature about HFD-induced inflammation and subsequent development of diseases and cancer, with an emphasis on mechanisms involved. Given the expanding global epidemic of excessive HFD intake, understanding the impacts of a HFD on these medical conditions, gaining great insights into possible underlying mechanisms, and developing effective therapeutic strategies are of great importance. INTRODUCTION At present, obesity has reached epidemic proportions. It develops from an imbalance of energy homeostasis and contributes dramatically to the global disease burden, predisposing individuals to chronic diseases such as type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and certain types of cancer (1, 2). Excessive consumption of high fat diets (HFDs) has undoubtedly exacerbated the obesity epidemic and the development of obesity-related metabolic disorders (3, 4). Despite substantial work demonstrating that obesity develops from an imbalance between energy intake and energy expenditure, the underlying mechanisms for the detrimental effects of HFDs seem to be more complicated than the simple concept of energy imbalance (5). In this context, a better understanding of the pathogenesis of HFD-driven metabolic disorders may help to reduce the disease burden worldwide. This review will elaborate on the precise pathology and etiology of diseases induced by a HFD, and will evaluate the possibility of therapeutic targeting of free fatty acids (FFAs) and low-grade systemic inflammation to reduce HFDs-stimulated diseases. HFDS INDUCE A SYSTEMIC CHRONIC LOW-GRADE INFLAMMATION Following the ingestion of HFDs, inflammation develops in the central nervous system (CNS) including the hypothalamus and in the peripheral tissues including the liver, adipose tissue, skeletal muscle, and intestine (6). Concerning the development of chronic systemic inflammation, alterations in the gut microbiota triggered by HFDs and direct effects of FFAs on intestinal cells may be the first step (7). Evidence to support this hypothesis is that germ-free mice exhibited neither obesity nor upregulation of intestinal TNF-α level compared to conventionalized mice when fed a HFD, whereas reconstitution of the gut microbiota from obese mice in the germ-free mice produced an increase in body fat (8). Furthermore, after comparing microbiota of obese vs. lean subjects, a recent study suggested that individuals with high bacterial richness were associated with less significant adiposity and inflammation than low bacterial richness subjects (9), which is line with HFD-induced inflammation and decrease of bacterial diversity. In particular, increased levels of Firmicutes and a reduced relative abundance of Bacteroidetes were observed in both humans and animals following HFD intake. Shifts in gut microbiota populations activate Toll-like receptor (TLR) signaling pathway, leading to increased intestinal permeability to endotoxins [such as lipopolysaccharides (LPS)] and thus promoting the translocation of LPS to the circulation (10–12). In addition, increased amounts of FFAs present in HFDs may directly act on intestinal cells. Therefore, elevated release of LPS and/or increased FFAs levels led to elevated production of pro-inflammatory cytokines [i.e., interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α] in the gut (13–17). The second step may consist in increased delivery of intestinal LPS, pro-inflammatory cytokines, and FFAs into the systemic circulation and portal circulation, thus leading to a systemic low-grade inflammation (15, 18). Elevated plasma FFAs and LPS can upregulate the expression of TLRs in circulating macrophages, enabling macrophages to be activated (M1 phenotype), which in turn produce proinflammmatory cytokines (11, 12). Before the onset of obesity, these factors in the circulating system triggers inflammatory pathways in the brain. More especially, elevated FFAs and cytokines first activate hypothalamic IκB kinase β (IKKβ)/nuclear factor of kappa B (NF-κB) signaling directly or indirectly through the following two ways: (i) through activating TLR located at cellular surface; (ii) through inducing various cellular stresses including oxidative stress and endoplasmic reticulum stress (ERS) in the hypothalamus (19–21). Hence, activated IKKβ/NF-κB signaling blunts central leptin and insulin sensitivity and initiates gene expression of inflammatory response molecules in the hypothalamus (19, 22, 23). Meanwhile, activated inflammatory macrophages (M1) in plasma can reach the adipose and muscular tissues, pancreatic islets, and blood vessels, leading to peripheral inflammation (12, 24). Notably, accumulation of CD8+ T-cells in the adipose tissue contributes to M1 macrophage recruitment in the adipose tissue (25). In addition, under HFD feeding stress the adipose tissue fails to store the excess lipids, which are thereafter deposited into other tissues including the liver, pancreas, skeletal muscle, and blood vessels (24). Ectopic lipid accumulation contributes additionally to the expression of proinflammatory mediators and the recruitment of M1 macrophages, thus aggravating systemic inflammation (26, 27). Moreover, the liver is also exposed to relatively high concentrations of different mediators (i.e., LPS, proinflammatory cytokines, and FFAs) released by the gastrointestinal tract (15). These mediators lead to accumulation of Natural killer T (NKT) cells and activation of Kupffer cells in the liver, thereby contributing to hepatic and systemic inflammation (28). Altogether, under HFD conditions, a complicated network of signals interconnecting several organs acts in synergy to elicit a low-grade systemic inflammation (Figure 1). HFD-related inflammation leads to the failure of adipocytes to effectively remove circulating FFAs, and is pivotal to disease progression and the development of complications, such as T2DM, CVD, liver disease, atherosclerosis, and certain types of cancer (Figure 2, discussed in detail below). [Figure: High-fat diets (HFDs) induce metabolic inflammation throughout the organism. The levels of endotoxins (e.g., LPS), circulating free fatty acids, and inflammatory mediators are increased in response to HFDs, resulting in low-grade systemic inflammation and altered homeostasis in many organs (see text).] [Figure: Chronic diseases and certain types of cancer are induced by high-fat diets.] HFD-INDUCED DISEASES Insulin resistance and T2DM Insulin resistance is the condition where the body fails to respond appropriately to circulating insulin, leading to the impaired systemic glucose clearance and uptake in several tissues including the adipose tissue, liver, and muscle (29). Exposure to a HFD often results in insulin resistance and pancreatic β cell dysfunction. For example, after only 3 days of HFD feeding, systemic insulin resistance, and glucose intolerance developed in mice (30). Other studies have also shown that mice fed a HFD for several weeks exhibited increased glucose intolerant and impaired insulin sensitive, reflecting insulin resistance and initiating β cell compensation (31, 32). Although not fully explored, current evidence has established causative and correlative links between HFD-induced inflammation and the pathogenesis of insulin resistance (27, 33). Under HFD conditions, insulin secretion from β cells and peripheral insulin action can be impaired by hypothalamic inflammation (34). Proinflammatory cytokines produced by β cells themselves due to macrophages accumulation in islets may further block β cell function (35). In addition, HFDs can activate 12- lipoxygenase activity in β cells through cytokines, FFAs, and increased blood glucose, thus increasing the production of 12-hydroxyeicosatetraenoic acid (12-HETE). 12-HETE promotes oxidative stress and blunts Nrf2 function, eventually leading to β cell apoptosis and glucose intolerance (36). Therefore, HFDs lead to

Read the complete text